Atlas Trials

Study Evaluating ERB-041 in Active Crohn's Disease

Clinical trial NCT00245947 · COMPLETED

Trial details

NCT number
NCT00245947
Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Crohn's Disease
Start date
2004-04-01
Primary completion
2005-04-01
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.